Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients
Clinical trial NCT03452501 · COMPLETED
Trial details
- NCT number
- NCT03452501
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-26
- Primary completion
- 2020-08-17
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.